Please provide your email address to receive an email when new articles are posted on . Five-year recurrence-free survival was 55.1% with nevus-associated acral melanoma (NAAM) vs. 42.3% with de novo ...

Stage IIC melanoma patients in Sweden face worse survival than stage IIIA. Learn how this may change follow-up and treatment guidelines.

Lymph node dissection, the standard surgical treatment for melanoma, does not increase patient survival rates, according to a study published in The New England Journal of Medicine. Lymph node ...

Opdivo, alone or with Yervoy, significantly improved 10-year OS and MSS in advanced melanoma compared to Yervoy alone, with OS rates of 43%, 37%, and 19%, respectively. The trial underscored the ...

About 90% of patients with advanced melanoma who had a complete response to first-line immune checkpoint inhibitors survived more than 3 years, with survival curves plateauing over time, a large ...

Regional anesthesia can improve survival rates in patients with malignant melanoma, the deadliest form of skin cancer, according to a study presented at this year’s American Society of ...

RP1 and nivolumab combination achieved a 32.9% objective response rate and 15.0% complete response rate in advanced melanoma patients post anti–PD-1 therapy failure. The treatment demonstrated durable ...

Mitotic rate ≥1/mm² and residual tumor presence are linked to higher relapse risk in cutaneous melanoma patients post-excision. Lymphovascular invasion significantly correlates with worse relapse-free ...

Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer MCMs were applied to patient-level ...

Please provide your email address to receive an email when new articles are posted on . Melanoma diagnoses were more common among women with skin of color vs. men. Non-Hispanic Black patients were ...

Phase I and Pharmacokinetic Study of the Oral Farnesyl Transferase Inhibitor SCH 66336 Given Twice Daily to Patients With Advanced Solid Tumors PURPOSE: Immune complexes (IC) containing the ...